Enzymotec Ltd. (ENZY) was a big mover last session, as the company saw its shares surge 15% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 30% in the past one-month time frame.
The company has seen 1 positive estimate revision in the past one month, while its Zacks Consensus Estimate moved higher over the same period, suggesting that more solid trading could be ahead for the company. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Enzymotec currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Other players in the same industry include GW Pharmaceuticals plc (GWPH) and ICU Medical, Inc. (ICUI) carrying a Zacks Rank #1(Strong Buy) along with Abaxis, Inc. (ABAX) with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment